OPKO Health ROA 2010-2024 | OPK
Current and historical return on assets (ROA) values for OPKO Health (OPK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| OPKO Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-06-30 | $-0.24B | $1.98B | -12.07% |
| 2024-03-31 | $-0.25B | $1.97B | -12.29% |
| 2023-12-31 | $-0.19B | $2.01B | -8.95% |
| 2023-09-30 | $-0.21B | $2.06B | -9.68% |
| 2023-06-30 | $-0.21B | $2.16B | -9.59% |
| 2023-03-31 | $-0.29B | $2.17B | -13.03% |
| 2022-12-31 | $-0.33B | $2.17B | -14.47% |
| 2022-09-30 | $-0.32B | $2.23B | -13.63% |
| 2022-06-30 | $-0.20B | $2.37B | -8.51% |
| 2022-03-31 | $-0.12B | $2.31B | -4.86% |
| 2021-12-31 | $-0.03B | $2.40B | -1.23% |
| 2021-09-30 | $0.08B | $2.42B | 3.09% |
| 2021-06-30 | $0.07B | $2.42B | 2.90% |
| 2021-03-31 | $0.12B | $2.52B | 5.00% |
| 2020-12-31 | $0.03B | $2.47B | 1.32% |
| 2020-09-30 | $-0.11B | $2.37B | -4.89% |
| 2020-06-30 | $-0.20B | $2.32B | -8.62% |
| 2020-03-31 | $-0.29B | $2.23B | -12.51% |
| 2019-12-31 | $-0.32B | $2.31B | -12.98% |
| 2019-09-30 | $-0.28B | $2.37B | -11.33% |
| 2019-06-30 | $-0.25B | $2.46B | -9.84% |
| 2019-03-31 | $-0.19B | $2.58B | -7.61% |
| 2018-12-31 | $-0.15B | $2.45B | -6.09% |
| 2018-09-30 | $-0.30B | $2.48B | -11.59% |
| 2018-06-30 | $-0.30B | $2.53B | -11.63% |
| 2018-03-31 | $-0.31B | $2.58B | -11.78% |
| 2017-12-31 | $-0.31B | $2.59B | -11.29% |
| 2017-09-30 | $-0.13B | $2.72B | -4.54% |
| 2017-06-30 | $-0.10B | $2.77B | -3.75% |
| 2017-03-31 | $-0.07B | $2.76B | -2.56% |
| 2016-12-31 | $-0.05B | $2.77B | -1.72% |
| 2016-09-30 | $-0.01B | $2.80B | -0.32% |
| 2016-06-30 | $0.13B | $2.77B | 4.71% |
| 2016-03-31 | $0.08B | $2.79B | 2.96% |
| 2015-12-31 | $-0.03B | $2.80B | -1.36% |
| 2015-09-30 | $-0.09B | $3.02B | -4.64% |
| 2015-06-30 | $-0.26B | $1.53B | -18.71% |
| 2015-03-31 | $-0.24B | $1.51B | -18.07% |
| 2014-12-31 | $-0.17B | $1.27B | -13.11% |
| 2014-09-30 | $-0.14B | $1.30B | -10.13% |
| 2014-06-30 | $-0.15B | $1.33B | -10.77% |
| 2014-03-31 | $-0.13B | $1.36B | -10.48% |
| 2013-12-31 | $-0.12B | $1.39B | -11.30% |
| 2013-09-30 | $-0.10B | $1.38B | -13.34% |
| 2013-06-30 | $-0.05B | $0.64B | -10.68% |
| 2013-03-31 | $-0.06B | $0.65B | -16.01% |
| 2012-12-31 | $-0.03B | $0.29B | -12.38% |
| 2012-09-30 | $-0.01B | $0.25B | -5.10% |
| 2012-06-30 | $-0.01B | $0.23B | -5.23% |
| 2012-03-31 | $-0.01B | $0.23B | -3.11% |
| 2011-12-31 | $-0.00B | $0.23B | -1.68% |
| 2011-09-30 | $-0.02B | $0.15B | -15.58% |
| 2011-06-30 | $-0.02B | $0.16B | -17.43% |
| 2011-03-31 | $-0.02B | $0.18B | -22.56% |
| 2010-12-31 | $-0.02B | $0.08B | -27.91% |
| 2010-09-30 | $-0.03B | $0.07B | -38.71% |
| 2010-06-30 | $-0.03B | $0.07B | -39.26% |
| 2010-03-31 | $-0.03B | $0.09B | -38.99% |
| 2009-12-31 | $-0.04B | $0.09B | -56.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.011B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| Edwards Lifesciences (EW) | United States | $38.832B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| Inari Medical (NARI) | United States | $3.035B | 0.00 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.668B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.291B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |